Project Number GC-2013000 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Targeting Ca2+ dysregulation in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Franke, Thomas Principal Investigator First Name Thomas Principal Investigator Last Name Franke Awardee Organization NEW YORK UNIVERSITY SCHOOL OF MEDICINE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $256,435 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
